Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: Nelson Peltz, Jim Chanos & Warren Buffett

Page 1 of 2

Shareholder Pressure Helped Lead to New MSG Board Members (NYTimes)
The Madison Square Garden Company surprised many on Monday when it announced — besides exploring a potential breakup of itself — that it was adding two financiers to its board, one being the activist investor Nelson Peltz. But unusually, it wasn’t Mr. Peltz, the veteran of several high-profile board battles, who pushed for a director position, according to people briefed on the matter. Mr. Peltz’s firm, Trian Fund Management, didn’t own any shares of Madison Square Garden as of Monday’s announcement.


Chanos takes profit on his top 2014 short sale: Brazil (HedgeCo)
Hedge fund manager Jim Chanos, the prominent short-seller, said Tuesday he has lightened up on some of his bets against Brazil, saying most of the country’s downside risk is priced in after the sharp selloff over the past two months. “Yes, we are still short but we’ve taken some profits,” Chanos said, speaking at a Reuters summit. “I think we’d be crazy not to.” Brazilian stocks have been hammered over worries about the country’s presidential election, which incumbent Dilma Rousseff narrowly won on Sunday.

SEC Charges New Jersey-Based Hedge Fund Manager with Insider Trading (HedgeCo)
The Securities and Exchange Commission filed insider trading charges against a New Jersey-based hedge fund manager who allegedly used material, nonpublic information to trade in advance of market-moving news concerning Carter’s Inc. Stephen Slawson, who lives in Lebanon, N.J., and was co-founder and former manager to a hedge fund named TCMP3 Partners L.P., becomes the eighth individual that the SEC has charged in connection with the agency’s investigation into insider trading and other misconduct involving the securities of the Atlanta-based marketer of children’s clothing.

Bill Ackman’s $90 million ‘One57’ Luxury Apartment Flip Slowing Down With Increased Empty Apartments Around It (InsiderMonkey)
Bill Ackman is an American Hedge fund manager, who is the founder and CEO of Pershing Square Capital Management. Ackman’s firm had a very successful 2014 with more than 25% returns in first half of the year. He is well known for some bold decisions like the investment in Allergan, Inc. (NYSE:AGN), betting on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to take over Allergan and effect a surge in Allergan’s stock, which turned out as he planned and returned big. In another bizarre move he is planning to flip a condominium in Manhattan, on which Ackman and a group of investors have invested $90 million. CNBC’s Frank Robert reported about this on CNBC.

Cliffs Natural shares jump after it says has enough liquidity (Reuters)
Shares of Cliffs Natural Resources Inc (NYSE:CLF) shot up as much as 25 percent after the miner said it had “more than enough” liquidity and that it was in talks with three “big steelmakers” to invest in its Bloom Lake iron ore mine in Quebec. Cliffs also said it had settled with its bankers and was no longer in breach of any debt covenants – a position that rose earlier this month after the miner’s plan to write down $6 billion in coal and iron ore assets. Chief Executive Lourenco Goncalves told Reuters that Cliffs was in “active talks” with three equity partners to invest in the development of the second phase of the Bloom Lake mine.

Allergan CEO: Huge momentum in sales growth (CNBC)

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!